Stok | Decarbonize Now In April 2024, Grosvenor published its North American Net Zero Carbon Pathway, developed by Stok The pathway defines a reductions-first approach to emissions reduction targeting a 42% overall reduction by 2030 and net zero by 2050
Stoke Therapeutics, Inc. (STOK) - Yahoo Finance Find the latest Stoke Therapeutics, Inc (STOK) stock quote, history, news and other vital information to help you with your stock trading and investing
Investors News - Stoke Therapeutics Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines
Stoke Therapeutics (STOK) Stock Price, News Analysis Should You Buy or Sell Stoke Therapeutics Stock? Get The Latest STOK Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat